Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 200 Total
EGIO - Edgio Inc - Stock Price Chart
TickerEGIO [NASD]
CompanyEdgio Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap9.14MEPS (ttm)-27.56
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-60.63%
P/S0.02EPS next 5Y15.00%
P/B0.06EPS Q/Q43.42%
Dividend-Sales Q/Q-19.91%
Insider Own44.15%Inst Own6.88%
Insider Trans-5.41%Inst Trans-36.30%
Short Float9.83%EarningsApr 25
Analyst Recom3.00Target Price50.00
Avg Volume2.04M52W Range0.72 - 44.00
Sep-09-24 10:05AM Apollo-Backed Software Maker Edgio Seeks Bankruptcy Protection (Bloomberg) -80.23%
09:29AM Edgio, Inc. Launches Strategic Financial Restructuring to Facilitate Sale and Strengthen Operations (Business Wire)
Aug-28-24 05:30PM Edgio, Inc. Receives Expected Notice from NASDAQ (Business Wire) -5.99% -10.24%
Aug-22-24 08:00AM BT Group and Edgio announce worlds first MAUD enabled Content Delivery Network (Business Wire) +18.44%
Aug-06-24 08:00AM Edgio Honored as Leader and Outperformer in GigaOm Platform Radar 2024 Report (Business Wire) +6.84%
Jun-07-24 08:00AM Edgio, Inc. Adopts Tax Benefits Preservation Plan Designed to Protect the Availability of Its Tax Benefits (Business Wire) -6.04%
May-21-24 04:30PM Edgio, Inc. Receives Expected Notice from NASDAQ (Business Wire)
May-15-24 09:00AM Edgio Empowers Vercara to Push the Boundaries of Performance & Security to the Edge (Business Wire) -5.92%
May-09-24 04:25PM Sinclair Broadcast Group, Inc. (NASDAQ:SBGI) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-06-24 12:00PM Edgio Named Winner of the Coveted Global InfoSec Awards During RSA Conference 2024 (Business Wire)
CNTA - Centessa Pharmaceuticals plc ADR - Stock Price Chart
TickerCNTA [NASD]
CompanyCentessa Pharmaceuticals plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap1.92BEPS (ttm)-1.56
P/E-EPS this Y0.09%
Forward P/E-EPS next Y-6.74%
PEG-EPS past 5Y-
P/S278.28EPS next 5Y-
P/B6.70EPS Q/Q-52.67%
Dividend-Sales Q/Q-
Insider Own33.28%Inst Own43.30%
Insider Trans-0.96%Inst Trans0.05%
Short Float2.61%EarningsAug 13/b
Analyst Recom1.29Target Price20.00
Avg Volume458.81K52W Range5.15 - 17.25
Sep-12-24 10:34PM Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares (GlobeNewswire) +9.82% +12.52%
Sep-11-24 04:04PM Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares (GlobeNewswire) -5.69%
Sep-10-24 04:34PM Centessa Reverses Lower Despite $5 Billion Narcolepsy Opportunity (Investor's Business Daily)
12:19PM Sleep-Disorder Focused Centessa Pharmaceuticals Unveils Interim Data From Lead Program In Acutely Sleep-Deprived Healthy Volunteers (Benzinga)
11:18AM Centessa Rockets To Three-Year High On $5 Billion Narcolepsy Opportunity (Investor's Business Daily)
08:15AM Investors are waking up to Centessas sleepiness drug (BioPharma Dive)
07:00AM Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers (GlobeNewswire)
Aug-27-24 08:00AM Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024) (GlobeNewswire)
Aug-24-24 01:18AM Insider Sale: Chief Business Officer Gregory Weinhoff Sells 30,000 Shares of Centessa ... (GuruFocus.com)
Aug-21-24 08:00AM Centessa Pharmaceuticals to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
ENLV - Enlivex Therapeutics Ltd - Stock Price Chart
TickerENLV [NASD]
CompanyEnlivex Therapeutics Ltd
CountryIsrael
IndustryBiotechnology
Market Cap33.61MEPS (ttm)-1.19
P/E-EPS this Y56.73%
Forward P/E-EPS next Y14.07%
PEG-EPS past 5Y32.51%
P/S-EPS next 5Y-
P/B1.15EPS Q/Q56.66%
Dividend-Sales Q/Q-
Insider Own12.70%Inst Own10.53%
Insider Trans0.00%Inst Trans-11.83%
Short Float0.51%EarningsAug 19
Analyst Recom1.00Target Price9.50
Avg Volume58.88K52W Range1.15 - 4.59
Sep-11-24 12:00PM All You Need to Know About Enlivex Therapeutics (ENLV) Rating Upgrade to Buy (Zacks)
Aug-30-24 09:00AM GreenPower and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
Jul-23-24 08:00AM Enlivex Receives Regulatory Authorization For The Initiation Of A Phase I Clinical Trial To Evaluate Allocetra In Patients With Psoriatic Arthritis (GlobeNewswire) +5.11%
Jul-19-24 09:00AM Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
Jun-24-24 08:00AM Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Trial Evaluating AllocetraTM in up to 46 Patients with Thumb Osteoarthritis (GlobeNewswire)
Jun-20-24 08:00AM Join Enlivex Therapeutics' Chief Executive Officer for a Live Investor Webinar and Q&A Session on June 25 (GlobeNewswire)
Jun-17-24 08:00AM Enlivex Announces Positive Interim Data Readout from a Phase I/II Trial Evaluating Allocetra in End-Stage Knee Osteoarthritis (GlobeNewswire)
Jun-03-24 08:00AM Enlivex Receives Regulatory Authorization for the Initiation of a Placebo-Controlled Phase I/II Trial Evaluating Allocetra in Up To 46 Patients with Thumb Osteoarthritis (GlobeNewswire) +8.09%
May-29-24 04:15PM Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering (GlobeNewswire) -5.07%
May-28-24 08:12AM Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering (GlobeNewswire)
FMF - First Trust Managed Futures Strategy Fund - Stock Price Chart
TickerFMF [NYSE]
CompanyFirst Trust Managed Futures Strategy Fund
CountryUSA
IndustryExchange Traded Fund
CategoryOther Asset Types - Multi-Asset / Other
Index-
Tagsfutures, equity, tactical
Sector/Theme Region
Dividend3.19%Active/Passive
Total Holdings85AUM217.95M
Flows% 1M48.89%Flows% 3M59.47%
Flows% YTD49.37%Flows% 1Y
Return% 1Y-0.07%Return% 3Y0.03%
Return% 5Y3.16%Return% 10Y
NAV% Expense
Avg Volume37.78K52W Range45.36 - 50.82
Dec-14-23 04:10PM First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds (Business Wire)
May-24-23 08:33AM Play Negative-Beta ETFs As U.S. Debt-Driven Deadlock Continues (Zacks)
Dec-14-22 04:05PM First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds (Business Wire)
Jul-08-19 09:21AM First Trust Morningstar Managed Futures Strategy Fund Changes Principal Investment Strategies and Name to First Trust Managed Futures Strategy Fund (Business Wire)
Jun-10-19 01:10AM How Much Of Famur S.A. (WSE:FMF) Do Institutions Own? (Simply Wall St.)
May-24-19 01:27AM Introducing Famur (WSE:FMF), A Stock That Climbed 81% In The Last Three Years (Simply Wall St.)
Dec-17-18 05:33PM First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds (Business Wire)
Aug-29-18 05:00AM Should You Be Happy With Famur SAs (WSE:FMF) Performance Lately? (Simply Wall St.)
Jun-22-18 05:25AM A Look At The Intrinsic Value Of Famur SA (WSE:FMF) (Simply Wall St.)
Jun-08-18 04:10AM Should You Sell Famur SA. (WSE:FMF) At This PE Ratio? (Simply Wall St.)
FARM - Farmer Bros. Co. - Stock Price Chart
TickerFARM [NASD]
CompanyFarmer Bros. Co.
CountryUSA
IndustryPackaged Foods
Market Cap49.09MEPS (ttm)-0.18
P/E-EPS this Y-210.53%
Forward P/E-EPS next Y44.07%
PEG-EPS past 5Y46.82%
P/S0.14EPS next 5Y30.00%
P/B1.08EPS Q/Q90.72%
Dividend-Sales Q/Q-1.29%
Insider Own20.17%Inst Own41.40%
Insider Trans0.00%Inst Trans1.39%
Short Float0.31%EarningsSep 12/a
Analyst Recom1.00Target Price6.00
Avg Volume46.18K52W Range1.86 - 4.04
Sep-12-24 04:25PM Farmer Brothers: Fiscal Q4 Earnings Snapshot (Associated Press Finance) -12.33%
04:05PM Farmer Brothers reports fourth quarter and full year fiscal 2024 financial results (GlobeNewswire)
Sep-11-24 09:05AM Farmer Bros Co (FARM) Q4 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Aug-26-24 04:15PM Farmer Brothers to report fourth quarter and fiscal 2024 financial results (GlobeNewswire)
Jul-02-24 05:16PM Farmer Brothers Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-22-24 04:30PM Farmer Brothers Names Vance Fisher Chief Financial Officer (GlobeNewswire) +7.14%
May-13-24 07:22AM More niches mean more opportunity Farmer Brothers on how different formats meet demand for coffee (Just Drinks)
May-10-24 12:04PM Farmer Bros. Co. (NASDAQ:FARM) Q3 2024 Earnings Call Transcript (Insider Monkey)
09:54AM Q3 2024 Farmer Bros Co Earnings Call (Thomson Reuters StreetEvents)
May-09-24 06:20PM Farmer Brothers (FARM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
STRM - Streamline Health Solutions, Inc - Stock Price Chart
TickerSTRM [NASD]
CompanyStreamline Health Solutions, Inc
CountryUSA
IndustryHealth Information Services
Market Cap13.87MEPS (ttm)-0.33
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-1.97%
P/S0.68EPS next 5Y15.00%
P/B0.87EPS Q/Q-4.48%
Dividend-Sales Q/Q-22.43%
Insider Own18.52%Inst Own27.74%
Insider Trans0.00%Inst Trans-0.67%
Short Float0.07%EarningsSep 11/a
Analyst Recom1.00Target Price1.50
Avg Volume82.99K52W Range0.21 - 1.02
Sep-11-24 04:30PM Streamline Health Reports Fiscal Second Quarter 2024 Financial Results (GlobeNewswire) +7.09% -48.39%
09:05AM Streamline Health Solutions Inc (STRM) Q2 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Sep-10-24 09:01AM Streamline Health Solutions Inc (STRM) Q2 2024 Earnings Report Preview: What to Expect (GuruFocus.com)
Sep-04-24 04:30PM Streamline Health To Report Fiscal Second Quarter 2024 Financial Performance (GlobeNewswire)
Jul-16-24 07:30AM Streamline Health Expands RevID Agreement With 400-Bed Children's Health System (GlobeNewswire)
Jul-02-24 07:30AM Streamline Health Announces New eValuator Contract with 750-Bed Academic Medical Center (GlobeNewswire)
Jun-13-24 08:01AM Streamline Health Solutions, Inc. (NASDAQ:STRM) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:26AM Q1 2024 Streamline Health Solutions Inc Earnings Call (Thomson Reuters StreetEvents)
Jun-11-24 08:52PM STRM Stock Earnings: Streamline Health Solns Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) +38.98% -19.53%
04:30PM Streamline Health Reports Fiscal First Quarter 2024 Financial Results (GlobeNewswire)
ALLR - Allarity Therapeutics Inc - Stock Price Chart
TickerALLR [NASD]
CompanyAllarity Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap4.81MEPS (ttm)-2221.83
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y57.56%
P/S-EPS next 5Y-
P/B0.20EPS Q/Q99.98%
Dividend-Sales Q/Q-
Insider Own35.21%Inst Own1.20%
Insider Trans0.00%Inst Trans-
Short Float1.73%EarningsMay 14/a
Analyst Recom1.00Target Price8.00
Avg Volume199.25K52W Range2.58 - 714.00
Sep-13-24 08:45AM Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +18.40%
Sep-11-24 08:00AM Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2) (GlobeNewswire) +11.02%
Aug-23-24 08:15AM Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Allarity Therapeutics, Inc. (NASDAQ: ALLR) for potential violations of federal securities laws (PR Newswire)
Aug-14-24 03:58PM Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Allarity Therapeutics, Inc. (NASDAQ: ALLR) for potential violations of federal securities laws (PR Newswire) +5.56%
Aug-08-24 08:05PM Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Allarity Therapeutics, Inc. (NASDAQ: ALLR) for potential violations of federal securities laws (PR Newswire)
Aug-02-24 09:18AM Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Allarity Therapeutics, Inc. (NASDAQ: ALLR) for potential violations of federal securities laws (PR Newswire) -8.56%
Jul-31-24 10:30AM Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Allarity Therapeutics, Inc. (NASDAQ: ALLR) for potential violations of federal securities laws (PR Newswire)
Jul-26-24 09:00AM Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting (GlobeNewswire) +14.90%
Jul-24-24 06:00AM Allarity Encourages Shareholders to Vote FOR the Reverse Stock Split and Decrease in Authorized Shares (GlobeNewswire) +7.33%
Jul-22-24 06:30AM Allarity Therapeutics Outlines Company's 2024 Progress and Objectives (GlobeNewswire)
UFO - Procure Space ETF - Stock Price Chart
TickerUFO [NASD]
CompanyProcure Space ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Factor & Thematic
IndexS-Network Space Index
TagsGlobal, equity, technology
Sector/Theme Region
Dividend1.02%Active/Passive
Total Holdings36AUM34.32M
Flows% 1M0.00%Flows% 3M-4.76%
Flows% YTD-14.47%Flows% 1Y
Return% 1Y7.91%Return% 3Y-0.14%
Return% 5Y-5.11%Return% 10Y
NAV% Expense
Avg Volume7.78K52W Range15.06 - 19.81
Jun-24-24 12:55PM Space ETFs: The final investing frontier? (Yahoo Finance Video)
Apr-18-24 10:35AM ProcureAM Celebrates Earth Day with Expense Reduction on Natural Disaster Recovery ETF (ACCESSWIRE)
Feb-14-24 01:53PM Investors can shoot for the stars with this space economy ETF (Yahoo Finance Video)
Nov-17-23 02:29PM Space stocks take a hit but deals could bring upside (Yahoo Finance)
Apr-20-23 01:01PM SpaceX Starship Exploded. Why the Launch Was Still Considered a Success. (Barrons.com)
09:58AM Starship From Elon Musks SpaceX Blows Up. Thats Not Bad News. (Barrons.com)
09:58AM SpaceX Starship Blows Up. Why It Was Still a Successful Launch. (Barrons.com)
Feb-15-23 07:15AM ProcureAM Announces Ticker Change for Disaster Recovery Strategy ETF (ACCESSWIRE)
Oct-06-22 03:55PM Space ETFs: Investors could see a '$1.7 trillion space economy by 2040,' expert says (Yahoo Finance Video)
Jul-25-22 12:04PM Space: Theres a huge market opportunity for some companies, strategist says (Yahoo Finance Video)
SMMT - Summit Therapeutics Inc - Stock Price Chart
TickerSMMT [NASD, RUT]
CompanySummit Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap23.13BEPS (ttm)-0.23
P/E-EPS this Y72.30%
Forward P/E-EPS next Y-9.48%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B118.56EPS Q/Q-304.27%
Dividend-Sales Q/Q-
Insider Own85.40%Inst Own10.00%
Insider Trans0.03%Inst Trans-29.20%
Short Float17.24%EarningsAug 06/b
Analyst Recom1.00Target Price24.67
Avg Volume3.60M52W Range1.64 - 28.62
Sep-14-24 11:44AM Is Summit Therapeutics Inc. (NASDAQ:SMMT) an Unstoppable Growth Stock To Buy Now? (Insider Monkey)
Sep-13-24 10:30AM Why Summit Therapeutics Skyrocketed 123% This Week (Motley Fool) +16.49%
Sep-12-24 04:06PM Summit Therapeutics, With 85% Gain This Week, Rockets Again On $235 Million Sale (Investor's Business Daily) +20.75%
11:53AM Why Summit Therapeutics Stock Is Soaring Again Today (Motley Fool)
06:30AM Summit Therapeutics Raises $235 Million (Business Wire)
Sep-11-24 07:08PM Summit Therapeutics Co-CEOs on what's next for lung cancer drug (CNBC TV)
Sep-10-24 04:27AM Is Summit Therapeutics a Buy Now? (Motley Fool) +20.01%
Sep-09-24 04:11PM Merck Dives After Summit Up 56% Sneaks In With Keytruda-Walloping Punch (Investor's Business Daily) +55.99%
02:01PM Why Summit Therapeutics Rocketed Over 60% Today (Motley Fool)
01:55PM A Better Drug Than Mercks Blockbuster Keytruda? Not So Fast (The Wall Street Journal)
INMB - INmune Bio Inc - Stock Price Chart
TickerINMB [NASD, RUT]
CompanyINmune Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap108.00MEPS (ttm)-2.06
P/E-EPS this Y-35.18%
Forward P/E-EPS next Y4.61%
PEG-EPS past 5Y-5.50%
P/S1199.99EPS next 5Y-
P/B2.90EPS Q/Q-39.37%
Dividend-Sales Q/Q-100.00%
Insider Own32.22%Inst Own23.09%
Insider Trans0.08%Inst Trans-4.43%
Short Float22.50%EarningsAug 01/a
Analyst Recom1.25Target Price20.25
Avg Volume184.37K52W Range5.80 - 14.74
Sep-13-24 08:30AM INmune Bio Announces $13.0 Million Registered Direct Offering (GlobeNewswire) -14.55%
Sep-03-24 09:00AM INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference (GlobeNewswire) -7.10%
Aug-01-24 04:05PM INmune Bio Inc. Announces Second Quarter 2024 Results and Provides Business Update (GlobeNewswire) -7.92%
Jul-29-24 09:00AM INmune Bio Inc. Announces New Phase 1 Study Data Demonstrating Dose-Dependent Effect of XPro on Proteins that Regulation Synapses in Alzheimer's Patients (GlobeNewswire)
Jul-25-24 08:00AM INmune Bio Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, August 1, 2024 (GlobeNewswire)
Jul-23-24 08:45AM INmune Bio Inc. Publishes Novel Biology on Natural Killer Cancer Immunotherapy INKmune in the Journal for ImmunoTherapy of Cancer (GlobeNewswire)
Jun-28-24 12:13PM INmune Bios unique Alzheimers trial endpoint receives validation (Clinical Trials Arena)
Jun-27-24 08:00AM INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer's Disease Trial (GlobeNewswire) +19.20%
May-30-24 08:00AM INmune Bio Inc. to Join Russell 3000 Index (GlobeNewswire)
May-13-24 11:54AM INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript (Insider Monkey)
1⋯345678910111213⋯20
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.